The news: CVS reported better-than-expected Q4 revenues while providing guidance for 2025 that pleased Wall Street. Shares of the company surged ~15% on the heels of Wednesday’s earnings report.

The topline numbers:

Q4 revenues hit $97.7 billion, up 4.2% year over year.
Full-year revenues increased to $372.8 billion, also up 4.2% YoY.
Full-year profits were $4.6 billion, but down about 45% from $8.4 billion the year prior.
Each of CVS’ business segments (health insurance, pharmacy and consumer wellness, and health services) beat expectations in Q4.

You've read 0 of 2 free articles this month.

Get more articles - create your free account today!

Products

Events & Resources

Topics

Latest Articles

Shoppers hate paying for return shipping more than any other part of the process

Doctors expect longer visits as parents seek clarity about pediatric vaccine guidelines

Lowe’s reaches out to Gen Alpha with new rewards program for kids

Meta faces critical questions as AI spending and regulatory scrutiny intensify

J&J launches direct-to-consumer prescription drug site with lower cash prices

The health and fitness industry’s future is subscription-first, not hardware-led

Scam exposure on social platforms threatens brands

Email is consumers’ top marketing channel, but inbox fatigue threatens ROI

How payment providers should react to OpenAI’s Instant Checkout walkback

Capital One joins finance industry layoff trend, sheds 1,100 Discover workers

About

CVS feels confident in a company turnaround this year

Coverage Areas →

Coverage Areas →

Advertising & Marketing

Health

Ecommerce & Retail

Technology

Financial Services

More Topics

Geographies

EMARKETER

Media Services

Free Content

Contact Us →

Worldwide HQ

Sales Inquiries